Published in Lancet Neurol on February 01, 2009
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol (2013) 4.29
The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Cerebral amyloid angiopathy in the elderly. Ann Neurol (2011) 2.84
Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol (2012) 2.62
Predictors of highly prevalent brain ischemia in intracerebral hemorrhage. Ann Neurol (2012) 2.59
Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol (2014) 2.39
Silent arteriovenous malformation hemorrhage and the recognition of "unruptured" arteriovenous malformation patients who benefit from surgical intervention. Neurosurgery (2015) 1.99
Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol (2010) 1.96
Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol (2011) 1.91
Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke (2012) 1.89
Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology (2014) 1.81
Vascular pathology in the aged human brain. Acta Neuropathol (2010) 1.78
Cerebral amyloid angiopathy: a systematic review. J Clin Neurol (2011) 1.77
Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study. Neurology (2011) 1.76
Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage. Alzheimers Dement (2015) 1.62
Cerebral amyloid angiopathy with and without hemorrhage: evidence for different disease phenotypes. Neurology (2015) 1.61
Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol (2010) 1.50
Clinical significance of cerebral microbleeds locations in CADASIL with R544C NOTCH3 mutation. PLoS One (2015) 1.44
Aortic Stiffness and the Risk of Incident Mild Cognitive Impairment and Dementia. Stroke (2016) 1.43
Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. Radiology (2011) 1.41
Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology (2013) 1.33
Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS (2013) 1.33
Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke (2014) 1.32
Hypertension: a harbinger of stroke and dementia. Hypertension (2013) 1.30
Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis (2013) 1.30
Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology (2012) 1.29
Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol (2012) 1.29
Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology (2010) 1.29
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol (2013) 1.27
Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging (2010) 1.25
Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping. Magn Reson Med (2012) 1.19
Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol (2012) 1.19
Apolipoprotein E genotype is associated with CT angiography spot sign in lobar intracerebral hemorrhage. Stroke (2012) 1.19
Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings. Neuroradiology (2013) 1.17
The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med (2014) 1.15
Incidence of symptomatic hemorrhage in patients with lobar microbleeds. Stroke (2014) 1.15
APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis. Neurology (2013) 1.14
Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors. Neuro Oncol (2016) 1.14
Aortic stiffness is associated with cardiac function and cerebral small vessel disease in patients with type 1 diabetes mellitus: assessment by magnetic resonance imaging. Eur Radiol (2009) 1.14
Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk. Front Neurol (2012) 1.14
Imaging of acute stroke. Nat Rev Neurol (2010) 1.09
International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep (2012) 1.09
Silent intralesional microhemorrhage as a risk factor for brain arteriovenous malformation rupture. Stroke (2012) 1.08
The Rotterdam Scan Study: design and update up to 2012. Eur J Epidemiol (2011) 1.07
Semiautomated detection of cerebral microbleeds in magnetic resonance images. Magn Reson Imaging (2011) 1.04
Microbleed detection using automated segmentation (MIDAS): a new method applicable to standard clinical MR images. PLoS One (2011) 1.03
Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study. Neurology (2015) 1.03
Cerebral microbleeds: overview and implications in cognitive impairment. Alzheimers Res Ther (2014) 1.02
Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp Gerontol (2012) 1.01
Thrombus imaging in acute stroke: correlation of thrombus length on susceptibility-weighted imaging with endovascular reperfusion success. Eur Radiol (2014) 1.01
Diabetes, markers of brain pathology and cognitive function: the Age, Gene/Environment Susceptibility-Reykjavik Study. Ann Neurol (2014) 1.01
Dynamic temporal change of cerebral microbleeds: long-term follow-up MRI study. PLoS One (2011) 1.00
Incidence of cerebral microbleeds in preclinical Alzheimer disease. Neurology (2014) 0.99
Comparison of acute and chronic traumatic brain injury using semi-automatic multimodal segmentation of MR volumes. J Neurotrauma (2011) 0.99
Posterior white matter disease distribution as a predictor of amyloid angiopathy. Neurology (2014) 0.98
Post-mortem assessment in vascular dementia: advances and aspirations. BMC Med (2016) 0.98
Modeling intracerebral hemorrhage growth and response to anticoagulation. PLoS One (2012) 0.98
Genetic associations with brain microbleeds: Systematic review and meta-analyses. Neurology (2011) 0.97
Differential effects of age and history of hypertension on regional brain volumes and iron. Neuroimage (2010) 0.94
Comparison of susceptibility weighted imaging and TOF-angiography for the detection of Thrombi in acute stroke. PLoS One (2013) 0.93
Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds. Neuropathol Appl Neurobiol (2014) 0.93
Cerebral microbleeds: their associated factors, radiologic findings, and clinical implications. J Stroke (2013) 0.93
Lipoprotein phospholipase A2 and cerebral microbleeds in the Framingham Heart Study. Stroke (2012) 0.93
Detection of cerebral microbleeds with quantitative susceptibility mapping in the ArcAbeta mouse model of cerebral amyloidosis. J Cereb Blood Flow Metab (2011) 0.92
Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy. Neurology (2014) 0.92
Cerebral microhemorrhage in Marchiafava-Bignami disease detected by susceptibility-weighted imaging. Neurol Sci (2012) 0.92
Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med (2014) 0.91
Susceptibility-weighted MR imaging of radiation therapy-induced cerebral microbleeds in patients with glioma: a comparison between 3T and 7T. Neuroradiology (2013) 0.91
The role of hippocampal iron concentration and hippocampal volume in age-related differences in memory. Cereb Cortex (2012) 0.90
Quantitative susceptibility mapping of small objects using volume constraints. Magn Reson Med (2012) 0.90
SCORE-IT: the Spot Sign score in restricting ICH growth─an Atach-II ancillary study. J Vasc Interv Neurol (2012) 0.88
Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: A meta-analysis. Neurology (2016) 0.88
Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminar. J Am Geriatr Soc (2013) 0.88
Intracerebral hemorrhage after intravenous thrombolysis in patients with cerebral microbleeds and cardiac myxoma. Front Neurol (2014) 0.88
Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities. J Diabetes Investig (2016) 0.87
The characteristics of superficial siderosis and convexity subarachnoid hemorrhage and clinical relevance in suspected cerebral amyloid angiopathy. Cerebrovasc Dis (2015) 0.86
Intracerebral hemorrhage and deep microbleeds associated with cnm-positive Streptococcus mutans; a hospital cohort study. Sci Rep (2016) 0.86
Computer-aided detection of radiation-induced cerebral microbleeds on susceptibility-weighted MR images. Neuroimage Clin (2013) 0.86
Advanced neuroimaging in traumatic brain injury. Semin Neurol (2013) 0.86
White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology (2016) 0.85
Current pathophysiological concepts in cerebral small vessel disease. Front Aging Neurosci (2014) 0.85
Increased visibility of deep medullary veins in leukoaraiosis: a 3-T MRI study. Front Aging Neurosci (2014) 0.85
Therapeutic strategies in acute intracerebral hemorrhage. Neurotherapeutics (2012) 0.85
Cerebral microbleeds and quality of life in acute ischemic stroke. Neurol Sci (2011) 0.85
Risk Factors Associated With Incident Cerebral Microbleeds According to Location in Older People: The Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study. JAMA Neurol (2015) 0.84
Cortical localization of microbleeds in cerebral amyloid angiopathy: an ultra high-field 7T MRI study. J Alzheimers Dis (2015) 0.84
The spectrum of MR detectable cortical microinfarcts: a classification study with 7-tesla postmortem MRI and histopathology. J Cereb Blood Flow Metab (2015) 0.84
Incidental Cerebral Microbleeds and Cerebral Blood Flow in Elderly Individuals. JAMA Neurol (2015) 0.83
The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice. Neurobiol Aging (2015) 0.83
New microbleeds after thrombolysis: contiguous thin-slice 3T MRI. Medicine (Baltimore) (2014) 0.83
The Rotterdam Scan Study: design update 2016 and main findings. Eur J Epidemiol (2015) 0.83
Unexpected recovery of function after severe traumatic brain injury: the limits of early neuroimaging-based outcome prediction. Neurocrit Care (2013) 0.82
Lobar microbleeds are associated with a decline in executive functioning in older adults. Cerebrovasc Dis (2014) 0.82
Cerebral microbleeds in a multiethnic elderly community: demographic and clinical correlates. J Neurol Sci (2014) 0.82
Genetics of subcortical vascular dementia. Exp Gerontol (2012) 0.82
Cerebral Microbleeds and White Matter Hyperintensities in Cognitively Healthy Elderly: A Cross-Sectional Cohort Study Evaluating the Effect of Arterial Stiffness. Cerebrovasc Dis Extra (2015) 0.82
Susceptibility-weighted imaging: current status and future directions. NMR Biomed (2016) 0.82
Fine Particulate Matter, Residential Proximity to Major Roads, and Markers of Small Vessel Disease in a Memory Study Population. J Alzheimers Dis (2016) 0.82
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology (2006) 8.97
Susceptibility weighted imaging (SWI). Magn Reson Med (2004) 8.58
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology (2001) 6.42
Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke (2004) 3.80
Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology (2008) 3.76
Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol (1999) 3.67
Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol (1995) 3.60
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology (2007) 3.56
Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke (2003) 3.12
The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg (1994) 3.06
Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain (2007) 2.93
Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke (2004) 2.92
Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke (1984) 2.86
Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol (2005) 2.85
Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology (2002) 2.42
MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol (2008) 2.40
Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications. Neurology (2006) 2.38
Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke (2007) 2.36
Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol (1971) 2.35
Prevalence and severity of microbleeds in a memory clinic setting. Neurology (2006) 2.29
Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke (1999) 2.12
improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke (2008) 2.09
Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain (2004) 2.07
Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol (2008) 2.03
Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry (2008) 1.99
Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke (2004) 1.96
Antiplatelet use after intracerebral hemorrhage. Neurology (2006) 1.88
Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke (2008) 1.87
Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke (2002) 1.82
Prevalence of MR evidence of diffuse axonal injury in patients with mild head injury and normal head CT findings. AJNR Am J Neuroradiol (1994) 1.78
Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke (2002) 1.74
Left ventricular hypertrophy is associated with cerebral microbleeds in hypertensive patients. Neurology (2004) 1.66
Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol (2008) 1.63
Retinal and cerebral microvascular signs and diabetes: the age, gene/environment susceptibility-Reykjavik study. Diabetes (2008) 1.62
Cerebral microhemorrhage. Stroke (2006) 1.58
APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathol Appl Neurobiol (2003) 1.53
MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology (1999) 1.50
Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI. Neurology (1996) 1.39
Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain (2006) 1.38
Detection of hemorrhagic hypointense foci in the brain on susceptibility-weighted imaging clinical and phantom studies. Acad Radiol (2007) 1.37
Cerebral microbleeds: accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection. Radiology (2008) 1.24
Cerebral microbleeds are associated with lacunar stroke defined clinically and radiologically, independently of white matter lesions. Stroke (2006) 1.23
Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. Radiology (1988) 1.22
MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol (1996) 1.20
Direct comparison of histology of microbleeds with postmortem MR images: a case report. Cerebrovasc Dis (2008) 1.18
Detection of intracranial hemorrhage with susceptibility-weighted MR sequences. AJNR Am J Neuroradiol (1999) 1.14
Assessment of lacunar hemorrhage associated with hypertensive stroke by echo-planar gradient-echo T2*-weighted MRI. Stroke (2000) 1.13
Cerebral microbleeds in CADASIL. Neurology (2001) 1.13
Impact of MRI markers in subcortical vascular dementia: a multi-modal analysis in CADASIL. Neurobiol Aging (2008) 1.13
Improved detection of metastatic melanoma by T2*-weighted imaging. AJNR Am J Neuroradiol (2006) 1.10
Detection of asymptomatic cerebral microbleeds: a comparative study at 1.5 and 3.0 T. Acad Radiol (2008) 1.10
Comparative magnetic resonance imaging at 1.5 and 3 Tesla for the evaluation of traumatic microbleeds. J Neurotrauma (2007) 1.08
Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg (2005) 1.07
Frequency of asymptomatic microbleeds on T2*-weighted MR images of patients with recurrent stroke: association with combination of stroke subtypes and leukoaraiosis. AJNR Am J Neuroradiol (2004) 1.05
Cerebral microbleeds and white matter changes in patients hospitalized with lacunar infarcts. J Neurol (2004) 0.99
MR detection of microhemorrhages in neurologically healthy adults. Neuroradiology (2002) 0.96
Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help? Stroke (2008) 0.95
Cerebral microbleeds: clinical and pathophysiological significance. J Neuroimaging (2007) 0.94
Does microbleed predict haemorrhagic transformation after acute atherothrombotic or cardioembolic stroke? J Neurol Neurosurg Psychiatry (2008) 0.94
Cerebral microbleeds: old leaks and new haemorrhages. Int J Stroke (2006) 0.93
Type of gradient recalled-echo sequence results in size and number change of cerebral microbleeds. AJNR Am J Neuroradiol (2008) 0.91
Dot-like hemosiderin spots on gradient echo T2*-weighted magnetic resonance imaging are associated with past history of small vessel disease in patients with intracerebral hemorrhage. J Neuroimaging (2004) 0.91
MRI of acute post-ischemic cerebral hemorrhage in stroke patients: diagnosis with T2*-weighted gradient-echo sequences. Neuroradiology (2001) 0.88
Fast spin-echo MR imaging of the brain and spine: current concepts. AJR Am J Roentgenol (1992) 0.86
[Analysis of dot-like hemosiderin spots using brain dock system]. No Shinkei Geka (2003) 0.85
Optimization of gradient-echo MR for calcium detection. AJNR Am J Neuroradiol (1994) 0.83
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet (2007) 8.68
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke (2003) 7.75
Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol (2007) 7.06
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Intra-individual change over time in DNA methylation with familial clustering. JAMA (2008) 6.17
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol (2012) 5.91
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimers Dement (2006) 5.05
Migraine as a risk factor for subclinical brain lesions. JAMA (2004) 5.02
Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes (2002) 4.97
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke (2004) 4.39
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37
Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol (2008) 3.98
Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92
Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2009) 3.91
Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80
Genome-wide association study of PR interval. Nat Genet (2010) 3.73
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71
Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation (2011) 3.68
Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol (2002) 3.54
A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol (2005) 3.49
Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA (2011) 3.40
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol (2011) 3.18
NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet (2009) 3.18
Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet (2012) 3.14
Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med (2010) 3.05
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03
Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke (2006) 3.03
Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain (2007) 2.93
Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility--Reykjavik study. Brain (2011) 2.90
Kidney function is related to cerebral small vessel disease. Stroke (2007) 2.77
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke (2014) 2.71
Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol (2013) 2.70
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
Navigation with electromagnetic tracking for interventional radiology procedures: a feasibility study. J Vasc Interv Radiol (2005) 2.67
Migraine headache in middle age and late-life brain infarcts. JAMA (2009) 2.65
Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium. PLoS One (2013) 2.65
Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain (2005) 2.59
Meta-analysis of genome-wide association data identifies two loci influencing age at menarche. Nat Genet (2009) 2.58
The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol (2013) 2.56
Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke (2009) 2.55
Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol (2004) 2.54
Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke (2006) 2.53
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc (2013) 2.47
Structural brain changes in migraine. JAMA (2012) 2.47
Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension (2004) 2.43
Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study. Lancet Neurol (2008) 2.39
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci (2009) 2.32
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31
Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol (2006) 2.31
Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol (2005) 2.28
Adverse oral health and cognitive decline: the health, aging and body composition study. J Am Geriatr Soc (2013) 2.27
Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality. Neurocrit Care (2012) 2.25
Computer-assisted segmentation of white matter lesions in 3D MR images using support vector machine. Acad Radiol (2008) 2.25
Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA (2012) 2.21
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation (2011) 2.17
Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes (2004) 2.17
Autoimmune limbic encephalitis. Clin Med (2011) 2.13
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke (2008) 2.09
Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke (2010) 2.04
Changes in normal-appearing white matter precede development of white matter lesions. Stroke (2013) 2.01
The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology (2011) 2.01
Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy. J Vasc Interv Radiol (2007) 2.00
Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan Study. Stroke (2012) 1.99
A 62-year-old man with fluctuating neurological deficits and skin lesions. JAMA Neurol (2013) 1.99
Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet (2011) 1.98
Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol (2005) 1.98
Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension (2012) 1.96
Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation (2011) 1.96
Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant. Stroke (2008) 1.94
Cerebral infarcts and cognitive performance: importance of location and number of infarcts. Stroke (2009) 1.93
Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol (2004) 1.93